ACOART Paclitaxel SVD:Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases
Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases
Sponsor: Acotec Scientific Co., Ltd
This NA trial investigates Coronary Disease and is currently ongoing. Acotec Scientific Co., Ltd leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
Aug 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Recruiting NA
-
Nov 2023 — Feb 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jun 2023 — Nov 2023 [monthly]
Recruiting NA
-
Sep 2022 — Jun 2023 [monthly]
Recruiting NA
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Acotec Scientific Co., Ltd
- Shanghai Tongji Hospital, Tongji University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .